Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse | Zendy

Pablo Labarga | Zendy; Eugenia Vispo | Zendy; Pablo Barreiro | Zendy; Sonia RodríguezNóvoa | Zendy; Javier Pinilla | Zendy; Judit Morelló | Zendy; Luz MartínCarbonero | Zendy; Paula Tuma | Zendy; J. Medraño | Zendy; Vincent Soriano | Zendy

Open Access

Rate and Predictors of Success in the Retreatment of Chronic Hepatitis C Virus in HIV/Hepatitis C Virus Coinfected Patients With Prior Nonresponse or Relapse

Author(s) -

Pablo Labarga,

Eugenia Vispo,

Pablo Barreiro,

Sonia RodríguezNóvoa,

Javier Pinilla,

Judit Morelló,

Luz MartínCarbonero,

Paula Tuma,

J. Medraño,

Vincent Soriano

Publication year - 2010

Publication title -

jaids journal of acquired immune deficiency syndromes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.162

H-Index - 157

eISSN - 1944-7884

pISSN - 1525-4135

DOI - 10.1097/qai.0b013e3181bd5ce1

Subject(s) - medicine , ribavirin , hepatitis c virus , gastroenterology , pegylated interferon , hepatitis c , confidence interval , viral load , immunology , virus

In hepatitis C virus (HCV)/HIV-coinfected patients who failed a course of suboptimal hepatitis C therapy, retreatment with adequate doses and duration of pegylated interferon (pegIFN) plus ribavirin (RBV) is advisable in the presence of compensated advanced liver fibrosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research